{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:00:34Z","timestamp":1792432834828,"version":"4.5.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170110"],"award-info":[{"award-number":["32170110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Glycyrrhetinic acid, a drug with anti-inflammatory effects, enhanced the activity of antipsoriatic efficacy. In this research, an ointment with glycyrrhetinic acid was prepaired as the major component and several other herbal monomers (astilbin, osthole, and momordin Ic) have antipsoriatic activity as minor components. Then an Imiquimod-induced psoriasis-like mouse model was established and the damaged skin condition of the administered group, the changes in the spleen index and the secretion of inflammatory factors in mouse skin were observed. Calcipotriol ointment was used as a positive control to compare the efficacy. Glycyrrhizic acid compound ointment significantly improved imiquimod-induced psoriasis in mice and reduced the secretion of TNF-\u03b1, IL-12, IL-17, and IL-23 in mouse skin, and showed a stronger therapeutic effect than calcipotriol ointment. Calcipotriol ointment did not significantly alleviate imiquimod-induced splenomegaly and did not significantly reduce the expression of IL-17 and IL-23 in mouse skin. Glycyrrhetinic acid compound ointment was more effective than calcipotriol and was dose-dependent in the treatment of imiquimod-induced psoriatic dermatitis in mice. Meanwhile,calcipotriol was not suitable for the treatment of Imiquimod -induced psoriasis-like mice.<\/jats:p>","DOI":"10.1371\/journal.pone.0290637","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:45:52Z","timestamp":1693316752000},"page":"e0290637","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice"],"prefix":"10.1371","volume":"18","author":[{"given":"Yanwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8108-0254","authenticated-orcid":true,"given":"Shuangyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"pone.0290637.ref001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1440-0960.2006.00262.x","article-title":"Immunopathogenesis of psoriasis","volume":"47","author":"MR Lee","year":"2006","journal-title":"Australas J Dermatol"},{"key":"pone.0290637.ref002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.12968\/bjon.2010.19.13.48856","article-title":"Psoriasis: characteristics, psychosocial effects and treatment options","volume":"19","author":"S. Ryan","year":"2010","journal-title":"Br J Nurs"},{"key":"pone.0290637.ref003","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions","volume":"130","author":"BB Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"pone.0290637.ref004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"CE Griffiths","year":"2007","journal-title":"The Lancet"},{"key":"pone.0290637.ref005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40360-020-00419-0","article-title":"18\u03b2-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.","volume":"21","author":"J Gao","year":"2020","journal-title":"BMC Pharmacol Toxicol."},{"key":"pone.0290637.ref006","doi-asserted-by":"crossref","first-page":"12548","DOI":"10.1111\/ics.12548","article-title":"18 \u03b2 \u2010Glycyrrhetinic acid: its core biological properties and dermatological applications","volume":"ics","author":"A Kowalska","year":"2019","journal-title":"Int J Cosmetic Sci."},{"key":"pone.0290637.ref007","doi-asserted-by":"crossref","first-page":"119101","DOI":"10.1016\/j.ijpharm.2020.119101","article-title":"Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid","volume":"578","author":"N Jin","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"key":"pone.0290637.ref008","first-page":"114","article-title":"Natural Treatment Alternative for Psoriasis: A Review on Herbal Resources.","volume":"11","author":"KK Singh","year":"2014","journal-title":"Journal of Applied Pharmaceutical Science"},{"key":"pone.0290637.ref009","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1084\/jem.20130291","article-title":"Epidermal IL-15R\u03b1 acts as an endogenous antagonist of psoriasiform inflammation in mouse and man","volume":"210","author":"G Bouchaud","year":"2013","journal-title":"Journal of Experimental Medicine"},{"key":"pone.0290637.ref010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"C Tillack","year":"2014","journal-title":"Gut"},{"key":"pone.0290637.ref011","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clindermatol.2007.08.013","article-title":"Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.","volume":"25","author":"C Albanesi","year":"2007","journal-title":"Clinics in Dermatology"},{"key":"pone.0290637.ref012","first-page":"871","volume-title":"Clinical Immunology (Fifth Edition).","author":"C. Albanesi","year":"2019"},{"key":"pone.0290637.ref013","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9440(10)63811-4","article-title":"Arginase 1 Overexpression in Psoriasis: Limitation of Inducible Nitric Oxide Synthase Activity as a Molecular Mechanism for Keratinocyte Hyperproliferation","volume":"162","author":"D Bruch-Gerharz","year":"2003","journal-title":"The American Journal of Pathology"},{"key":"pone.0290637.ref014","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3390\/ijms20102558","article-title":"Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis","volume":"20","author":"T-H Huang","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"pone.0290637.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1980456","article-title":"The Protective Effects of 18 \u03b2 -Glycyrrhetinic Acid on Imiquimod-Induced Psoriasis in Mice via Suppression of mTOR\/STAT3 Signaling","volume":"2020","author":"H Chen","year":"2020","journal-title":"Journal of Immunology Research"},{"key":"pone.0290637.ref016","first-page":"3789","article-title":"Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK","volume":"17","author":"J Yu","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"pone.0290637.ref017","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/ijms21031006","article-title":"Phytochemistry, Ethnopharmacology, Pharmacokinetics and Toxicology of bitter melanin IC.","volume":"21","author":"Y Sun","year":"2020","journal-title":"International Journal of Molecular Sciences."},{"key":"pone.0290637.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5522164","article-title":"Kochia scoparia Saponin Momordin Ic Modulates HaCaT Cell Proliferation and Apoptosis via the Wnt\/\u03b2-Catenin Pathway.","volume":"2021","author":"M Luo","year":"2021","journal-title":"Evidence-Based Complementary and Alternative Medicine."},{"key":"pone.0290637.ref019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice.","volume":"16","author":"S Zhang","year":"2016","journal-title":"BMC Complem Altern M"},{"key":"pone.0290637.ref020","doi-asserted-by":"crossref","first-page":"e148510","DOI":"10.1172\/jci.insight.148510","article-title":"Nociceptor neurons promote IgE class switch in B cells.","volume":"6","author":"S Mathur","year":"2021","journal-title":"JCI Insight"},{"key":"pone.0290637.ref021","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Y Cai","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"pone.0290637.ref022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-4632.2011.05154.x","article-title":"The roles of cells and cytokines in the pathogenesis of psoriasis","volume":"51","author":"S Coimbra","year":"2012","journal-title":"Int J Dermatol"},{"key":"pone.0290637.ref023","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of Psoriasis: Recent Advances on IL-23 and Th17 Cytokines.","volume":"9","author":"E Fitch","year":"2007","journal-title":"Curr Rheumatol Rep."},{"key":"pone.0290637.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-662-09709-0_1","article-title":"The Stability and Reversibility of Th1 and Th2 Populations.","volume-title":"Redirection of Th1 and Th2 Responses.","author":"RL Coffman","year":"1999"},{"key":"pone.0290637.ref025","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3390\/molecules25225295","article-title":"Antioxidant and Anti-Inflammatory Activities of Six Flavonoids from Smilax glabra Roxb.","volume":"25","author":"X Zhao","year":"2020","journal-title":"Molecules"},{"key":"pone.0290637.ref026","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00128071-200102020-00008","article-title":"Calcipotriol Ointment.","volume":"2","author":"LJ Scott","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"pone.0290637.ref027","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","article-title":"Comorbidities associated with psoriasis: An experience from the Middle East","volume":"37","author":"N Al-Mutairi","year":"2010","journal-title":"The Journal of Dermatology"},{"key":"pone.0290637.ref028","article-title":"Psoriasis Clinical Implications and Treatment: A Review.","volume":"30","author":"AS Raut","year":"2013","journal-title":"CRT"},{"key":"pone.0290637.ref029","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/ptr.6973","article-title":"Potential herbal constituents for psoriasis treatment as protective and effective therapy.","volume":"35","author":"N Dabholkar","year":"2021","journal-title":"Phytotherapy Research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:46:20Z","timestamp":1693316780000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0290637"}},"subtitle":[],"editor":[{"given":"Masanori A.","family":"Murayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0290637","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}